| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Nicotine 291.667 microgram/hour prolonged-release transdermal patch |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| alfentanil (som alfentanilhydroklorid) 5 mg/10 ml, injektionsvätska, lösning, ampull |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely nicotine 312.5 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| alfentanil (som alfentanilhydroklorid) 500 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| alfentanil (som alfentanilhydroklorid) 500 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely glyceryl trinitrate 416.667 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| alfentanil (som alfentanilhydroklorid) 1 mg/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Nicotine 583.333 microgram/hour prolonged-release transdermal patch |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| alfakalcidol 2 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| alfakalcidol 2 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Glyceryl trinitrate 625 microgram/hour prolonged-release transdermal patch |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| alprostadil 500 mikrogram/ml, infusionsvätska, lösning, ampull |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| alprostadil 500 mikrogram/ml, infusionsvätska, lösning, ampull |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Nicotine 625 microgram/hour prolonged-release transdermal patch |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely rotigotine 250 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely nicotine 875 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely nicotine 937.5 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| darbepoetin alfa 500 mikrogram/ml, injektionsvätska, lösning, spruta |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| darbepoetin alfa 500 mikrogram/ml, injektionsvätska, lösning, spruta |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| eptifibatid 75 mg/100 ml, infusionsvätska, lösning, flaska |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| desmopressinacetat 4 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| desmopressinacetat 4 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| ergonovinmaleat 500 mikrogram/ml + oxytocin 5 enheter/ml, injektionsvätska, lösning, ampull |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| ergonovinmaleat 500 mikrogram/ml + oxytocin 5 enheter/ml, injektionsvätska, lösning, ampull |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| atenolol 5 mg/10 ml, injektionsvätska, lösning, ampull |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| fentanyl (som fentanylcitrat) 500 mikrogram/10 ml, injektionsvätska, lösning, ampull |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| fentanyl (som fentanylcitrat) 500 mikrogram/10 ml, injektionsvätska, lösning, ampull |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| digoxin 500 mikrogram/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| digoxin 500 mikrogram/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| oktreotid (som oktreotidacetat) 100 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| oktreotid (som oktreotidacetat) 100 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| oktreotid (som oktreotidacetat) 1 mg/5 ml, injektionsvätska, lösning, flaska |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| oktreotid (som oktreotidacetat) 500 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| oktreotid (som oktreotidacetat) 500 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| skopolaminhydrobromid 400 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| skopolaminhydrobromid 400 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| oktreotid (som oktreotidacetat) 50 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| oktreotid (som oktreotidacetat) 50 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| skopolaminhydrobromid 600 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| skopolaminhydrobromid 600 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| protirelin 200 mikrogram/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| protirelin 200 mikrogram/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| zikonotid (som zikonotidacetat) 100 mikrogram/ml, injektionsvätska, lösning, flaska |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| zikonotid (som zikonotidacetat) 100 mikrogram/ml, injektionsvätska, lösning, flaska |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Estradiol hemihydrate 150 microgram/actuation nasal spray |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Dexamethasone isonicotinate 20 microgram and tramazoline hydrochloride 120 microgram/actuation nasal spray |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Dexamethasone isonicotinate 20 microgram and tramazoline hydrochloride 120 microgram/actuation nasal spray |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
2 |
| zikonotid (som zikonotidacetat) 500 mikrogram/5 ml, injektionsvätska, lösning, flaska |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| zikonotid (som zikonotidacetat) 500 mikrogram/5 ml, injektionsvätska, lösning, flaska |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Glyceryl trinitrate 400 microgram/actuation sublingual spray |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely ferrous sulfate 150 milligram and folic acid 500 microgram/1 each prolonged-release oral capsule (clinical drug) |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Desmopressin acetate 10 microgram/actuation nasal spray |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely digoxin 50 microgram/1 milliliter conventional release oral solution (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| hepatit B-ytantigen 20 mikrogram/ml, injektionsvätska, suspension, spruta |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| hepatit B-ytantigen 20 mikrogram/ml, injektionsvätska, suspension, spruta |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Beclometasone dipropionate 50 microgram/actuation nasal spray |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| peginterferon alfa-2a 180 mikrogram/0,5 ml, injektionsvätska, lösning, spruta |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| peginterferon alfa-2a 180 mikrogram/0,5 ml, injektionsvätska, lösning, spruta |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| palonosetron (som palonosetronhydroklorid) 250 mikrogram/5 ml, injektionsvätska, lösning, flaska |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| palonosetron (som palonosetronhydroklorid) 250 mikrogram/5 ml, injektionsvätska, lösning, flaska |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely granisetron (as granisetron hydrochloride) 200 microgram/1 milliliter conventional release oral solution (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Budesonide 100 microgram/actuation nasal spray |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Fluticasone propionate 50 microgram/actuation nasal spray |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Ipratropium bromide 21 microgram/actuation nasal spray |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| parikalcitol 5 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| parikalcitol 5 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Mometasone furoate 50 microgram/actuation nasal spray |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| parikalcitol 10 mikrogram/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| parikalcitol 10 mikrogram/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Triamcinolone acetonide 55 microgram/actuation nasal spray |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Buserelin (as buserelin acetate) 100 microgram/actuation nasal spray |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| metoxipolyetylenglykol-epoetin beta 150 mikrogram/0,3 ml, injektionsvätska, lösning, spruta |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| metoxipolyetylenglykol-epoetin beta 150 mikrogram/0,3 ml, injektionsvätska, lösning, spruta |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| metoxipolyetylenglykol-epoetin beta 200 mikrogram/0,3 ml, injektionsvätska, lösning, spruta |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| metoxipolyetylenglykol-epoetin beta 200 mikrogram/0,3 ml, injektionsvätska, lösning, spruta |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| metoxipolyetylenglykol-epoetin beta 250 mikrogram/0,3 ml, injektionsvätska, lösning, spruta |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| metoxipolyetylenglykol-epoetin beta 250 mikrogram/0,3 ml, injektionsvätska, lösning, spruta |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| metoxipolyetylenglykol-epoetin beta 50 mikrogram/0,3 ml, injektionsvätska, lösning, spruta |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| metoxipolyetylenglykol-epoetin beta 50 mikrogram/0,3 ml, injektionsvätska, lösning, spruta |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| pentagastrin 500 mikrogram/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| pentagastrin 500 mikrogram/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| metoxipolyetylenglykol-epoetin beta 75 mikrogram/0,3 ml, injektionsvätska, lösning, spruta |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| metoxipolyetylenglykol-epoetin beta 75 mikrogram/0,3 ml, injektionsvätska, lösning, spruta |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| ganirelix 250 mikrogram/0,5 ml, injektionsvätska, lösning, spruta |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| ganirelix 250 mikrogram/0,5 ml, injektionsvätska, lösning, spruta |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| xylometazolinhydroklorid 500 mikrogram/milliliter, näsdroppar, lösning |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Nicotine 500 microgram/actuation nasal spray |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| isosorbiddinitrat 25 mg/50 ml, injektionsvätska, lösning, flaska |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Azelastine hydrochloride 140 microgram/actuation nasal spray |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| iloprost (som iloporosttrometamin) 100 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| iloprost (som iloporosttrometamin) 100 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| naloxonhydroklorid 40 mikrogram/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| naloxonhydroklorid 40 mikrogram/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| naloxonhydroklorid 400 mikrogram/ml, injektionsvätska, lösning, spruta |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| naloxonhydroklorid 400 mikrogram/ml, injektionsvätska, lösning, spruta |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| levobupivakain (som levobupivakainhydroklorid) 62,5 mg/100 ml, injektionsvätska, lösning, påse |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| naloxonhydroklorid 800 mikrogram/2 ml, injektionsvätska, lösning, spruta |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| naloxonhydroklorid 800 mikrogram/2 ml, injektionsvätska, lösning, spruta |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| levobupivakain (som levobupivakainhydroklorid) 125 mg/200 ml, injektionsvätska, lösning, påse |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Fluticasone furoate 27.5 microgram/actuation nasal spray |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Flunisolide 25 microgram/actuation nasal spray |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |